NASDAQ:IBBiShares Nasdaq Biotechnology ETF Stock Price, Forecast & News

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IBB stock has increased by 26.1% and is now trading at $134.87.
View which stocks have been most impacted by Coronavirus.

iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be given a dividend of $0.0554 per share on Tuesday, March 31st. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date of this dividend is Wednesday, March 25th.
View iShares Nasdaq Biotechnology ETF's dividend history.

iShares Nasdaq Biotechnology ETF's stock split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

News headlines about IBB stock have trended positive on Tuesday, InfoTrie reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a media sentiment score of 2.8 on InfoTrie's scale. They also assigned news stories about the financial services provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term.
View the latest news about iShares Nasdaq Biotechnology ETF.

iShares Nasdaq Biotechnology ETF saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 20,730,000 shares, an increase of 22.7% from the December 31st total of 16,890,000 shares. Based on an average daily trading volume, of 2,555,300 shares, the short-interest ratio is presently 8.1 days.
View iShares Nasdaq Biotechnology ETF's Short Interest.

Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Royce Value Trust (RVT), Hercules Capital (HTGC), Gabelli Equity Trust (GAB), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), Blackrock Muniyield Insured Fund (MYI), Tortoise Energy Infrastructure (TYG), AllianceBernstein Global Hgh Incm Fd (AWF), Tekla Healthcare Investors (HQH) and Invesco Van Kampen Munpl Oprtnty Tr (VMO).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Netflix (NFLX), Cisco Systems (CSCO), Tesla (TSLA), Bank of America (BAC), Paypal (PYPL), Micron Technology (MU) and Johnson & Johnson (JNJ).

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include CHURCHILL MANAGEMENT Corp (2.24%), PNC Financial Services Group Inc. (0.91%), Envestnet Asset Management Inc. (0.60%), Total Investment Management Inc. (0.42%), Raymond James & Associates (0.29%) and DAVENPORT & Co LLC (0.29%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Estate Counselors LLC, Sawtooth Solutions LLC, AE Wealth Management LLC, Janney Capital Management LLC, Simplex Trading LLC, Quattro Financial Advisors LLC, Fulton Bank N. A., and Valicenti Advisory Services Inc..

IBB stock was purchased by a variety of institutional investors in the last quarter, including CHURCHILL MANAGEMENT Corp, Envestnet Asset Management Inc., Total Investment Management Inc., DAVENPORT & Co LLC, SG Americas Securities LLC, PNC Financial Services Group Inc., Cambridge Investment Research Advisors Inc., and Raymond James & Associates.

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $134.87.

iShares Nasdaq Biotechnology ETF has a market capitalization of $9.58 billion.